We have been successful in securing multiple collaborations with leading international partners to develop novel solid dose ImplaVax®-enabled vaccines designed to prevent and treat a wide range of infectious diseases, allergies and other diseases. This demonstrates the broad potential of our ImplaVax® formulations against many diseases across all vaccine formats.